Literature DB >> 20845914

Biotemplated aqueous-phase palladium crystallization in the absence of external reducing agents.

Jung-Sun Lim1, Seung-Min Kim, Sang-Yup Lee, Eric A Stach, James N Culver, Michael T Harris.   

Abstract

A new synthetic strategy enabling highly controlled aqueous-phase palladium crystallization on the tobacco mosaic virus (TMV) is demonstrated without the addition of external reducing agents. This low cost, solution processing method yields continuous and uniform coatings of polycrystalline palladium on TMV, creating highly uniform palladium nanowires of tens of nanometers in thickness and hundreds of nanometers in length. Our approach utilizes a palladium chloride precursor to produce metallic Pd coatings on TMV without the need for an external reducing agent. X-ray photoelectron spectroscopy and in situ transmission electron microscopy were used to confirm the reduction of the surface palladium oxide layer on the palladium metal wires during room temperature hydrogenation. This leads to metallic palladium nanowires with surfaces free of residual organics, making these structures suitable for applications in nanoscale electronics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20845914     DOI: 10.1021/nl101375f

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  2 in total

1.  Biotemplating rod-like viruses for the synthesis of copper nanorods and nanowires.

Authors:  Jing C Zhou; Carissa M Soto; Mu-San Chen; Michael A Bruckman; Martin H Moore; Edward Barry; Banahalli R Ratna; Pehr E Pehrsson; Bradley R Spies; Tammie S Confer
Journal:  J Nanobiotechnology       Date:  2012-05-01       Impact factor: 10.435

2.  A Genetically Modified Tobacco Mosaic Virus that can Produce Gold Nanoparticles from a Metal Salt Precursor.

Authors:  Andrew J Love; Valentine V Makarov; Olga V Sinitsyna; Jane Shaw; Igor V Yaminsky; Natalia O Kalinina; Michael E Taliansky
Journal:  Front Plant Sci       Date:  2015-11-10       Impact factor: 5.753

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.